What one share of Exozymes holds
Exozymes’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$1.20 |
|---|---|
| Capex (buildings and equipment) | $0.02 |
| Free cash flow | −$0.84 |
| Cash and investments | $0.61 |
| Book value | $0.39 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2023 | $0.01 | −$0.33 | $0.05 | −$0.24 | — | −$0.06 |
| 2024 | — | −$0.89 | $0.06 | −$1.36 | — | $1.25 |
| 2025 | — | −$1.09 | $0.02 | −$0.80 | — | $0.40 |
Common questions about Exozymes
How much does one share of Exozymes earn?
Over the last 12 months, Exozymes lost $1.20 for each share.
Does Exozymes pay a dividend?
Exozymes didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Exozymes’s book value per share?
Exozymes’s book value is $0.39 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Exozymes have?
Each share of Exozymes has $0.61 of cash and investments, as of June 30, 2026.
What is Exozymes’s free cash flow per share?
−$0.84 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.